Friday, July 20, 2018
 
 
Company News: Page (1) of 1 - 07/04/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Newborn Screening Market Report Analysis With Industry Players Like PerkinElmer, Trivitron Healthcare, Interacoustics A/S, Bio-Rad Laboratories and More

(July 04, 2018)


"Global Newborn Screening Market"
Newborn Screening Market Analysis By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases Test), Product Type (Instruments, Reagents & Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays And Enzymatic Assays, Electrophoresis, DNA-Based Assays), Diseases Type, End User and More

Newborn Screening Market was valued at USD 1,008.64 million in 2017, and is expected to reach USD 2,258.12 million by 2025, growing at a CAGR of 10.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Major factors contributing to the growth of the market includes factors such as rising prevalence of new born screening, growth in neonatal diseases, increased government funding and technological advancements. On the other hand, high cost of automated devices and stringent regulatory policies are restricting the growth of the market.

Get Free Sample PDF of This Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-newborn-screening-market

The key market players for global newborn screening market are listed below:

  • PerkinElmer Inc.
  • Trivitron Healthcare
  • Interacoustics A/S
  • Bio-Rad Laboratories, Inc.
  • Natus Medical Incorporated
  • Masimo
  • Medtronic
  • Intelligent Hearing Systems
  • Interacoustics A/S
  • Otodynamics Ltd
  • Vivosonic Inc.
  • ZenTech S.A.
  • AB Sciex
  • Welch Allyn
  • Baebies, Inc.

The Global Newborn Screening Market is segmented on the basis of test types into dried blood spot (DBS) test, critical congenital heart diseases (CCHD) test and hearing screen test. In 2018, dried blood spot is anticipated to lead the market with 44.0% shares and will grow at USD 974.54 million by 2025. It is exceeding at the CAGR of 10.4% in the forecast period.

The global newborn screening market is divided based on product type into instruments and reagents & assay kits. In 2018, the instruments market is estimated to dominate market with 67.7% shares and will collect around 1,553.89 million by 2025, rising at the maximum CAGR of 11.0%. The instruments are further sub- segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

On the basis of technologies, the global newborn screening market is segmented into tandem mass spectrometry, hearing screen, pulse oximetry screening, immunoassays and enzymatic assays, electrophoresis and DNA-based assays. In 2018, tandem mass spectrometry market is likely to dominate market with 26.9% shares and is estimated to reach 647.98 million by 2025. It is growing at the highest CAGR of 11.7% in the forecast period.

The global newborn screening market is categorized based on disease type into phenylketonuria, cystic fibrosis, sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease and others. In 2018, critical congenital heart diseases market will dominate with 64.8% shares and will consume around 1,492.98 million by 2025. It is growing at the highest CAGR of 11.0% in the assessment period.

The global newborn screening market is divided on the basis of end user into hospitals, pediatric clinics, and clinics. In 2018, hospitals market is expected to dominate market with 71.3% shares and is estimated to reach 1,633.21 million by 2025, growing at the highest CAGR of 10.9%.

North America Industry Segmentation

North America newborn screening market is estimated to reach USD 1,018.49 million by 2025 from USD 458.93 million in 2017, at a CAGR of 10.6% in the forecast period 2018 to 2025.

Test Type: Dried blood spot is anticipated to lead the market with 43.0% shares and will cross USD 430.34 million by 2025. It is exceeding at the CAGR of 10.3% in the forecast period.

Product Type: Rising at the maximum CAGR of 10.9%. The instruments segment is further sub- segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

Technology: Tandem mass spectrometry market is likely to dominate market with 26.5% shares and is estimated to reach 295.44 million by 2025. It is growing at the highest CAGR of 12.0% in the forecast period.

Disease Type: Critical congenital heart diseases market will dominate with 64.4% shares and will consume around 670.15 million by 2025. It is growing at the highest CAGR of 10.9% in the assessment period.

End-user: Hospitals market is expected to dominate market with 71.0% shares and is estimated to reach 734.96 million by 2025, growing at the highest CAGR of 10.8%.

Europe Industry Segmentation

Europe newborn screening market is projected to cross USD 564.45 million by 2025 from USD 248.13 million in 2017, at a CAGR of 10.9% in the forecast period 2018 to 2025.

Test Type: Dried blood spot is anticipated to lead the market with 44.0% shares and will grow at USD 243.68 million by 2025. It is exceeding at the CAGR of 10.6% in the forecast period.

Product Type: Instruments market is estimated to dominate market with 67.8% shares and will collect around 388.35 million by 2025, rising at the maximum CAGR of 11.2%. The instruments are further sub- segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

Technology: Tandem mass spectrometry market is likely to dominate market with 26.9% shares and is estimated to reach 158.66 million by 2025. It is growing at the highest CAGR of 11.6% in the forecast period.

Disease Type: Critical congenital heart diseases market will dominate with 64.8% shares and will consume around 373.20 million by 2025. It is growing at the highest CAGR of 11.2% in the assessment period.

End-user: Hospitals market is expected to dominate market with 71.1% shares and is estimated to reach 407.47 million by 2025, growing at the highest CAGR of 11.2%.

Speak to Research Analyst for Regional Customization or Other Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-newborn-screening-market

Asia-Pacific Industry Segmentation

Asia Pacific newborn screening market is expected to reach USD 432.41 million by 2025 from USD 185.59 million in 2017, at a CAGR of 11.3% in the forecast period 2018 to 2025.

Test Type: Dried blood spot is anticipated to lead the market with 44.3% shares and will grow at USD 187.47 million by 2025. It is exceeding at the CAGR of 10.9% in the forecast period.

Product Type: Instruments market is estimated to dominate market with 68.0% shares and will collect around 298.02 million by 2025, rising at the maximum CAGR of 11.5%. The instruments are further sub- segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

Technology:  Tandem mass spectrometry market is likely to dominate market with 27.2% shares and is estimated to reach 122.47 million by 2025. It is growing at the highest CAGR of 11.9% in the forecast period.

Disease Type: Critical congenital heart diseases market will dominate with 65.1% shares and will consume around 286.45 million by 2025. It is growing at the highest CAGR of 11.5% in the assessment period.

End-user: Hospitals market is expected to dominate market with 71.4% shares and is estimated to reach 312.88 million by 2025, growing at the highest CAGR of 11.5%.

Table Of Content

1. Introduction

1.1. Objectives Of The Study

1.2. Market Definition1.3. Overview Of Global Newborn Screening Market


1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation

2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview

3.1. Drivers

3.1.1. Rising Prevalence Of Newborn Screening
3.1.2. Growth In Neonatal Diseases
3.1.3. Increased Government Initiatives
3.1.4. Technological Advancements In Screening

3.2. Restraints

Continue…

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-newborn-screening-market

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: [email protected]
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-newborn-screening-market/



Source: www.abnewswire.com


Page: 1


Related Keywords:Health & Medicine,News & Current Affairs,Pharmaceuticals & Biotech,Retail,World,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines